GLMD   $3.79  9.54% Market Closed After Close 3.9 2.90%

Galmed Pharmaceuticals Ltd
Last Events:

2023-08-06 Trend pattern changed from канал to нисходящий клин.

2023-08-06 Signal in Stochastic changed from bearish weakening to bearish recovery. The stochastic indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: main and signal line crossing.

2023-08-05 Trend pattern changed from сужающийся канал to канал.

2023-08-05 Signal in Stochastic changed from bearish recovery to bearish weakening. The stochastic indicator is in the oversold territory and it grows. These factors indicate that perhaps the downside trend is coming to an end. Last signal: main and signal line crossing.

2023-08-03 Trend pattern changed from нисходящий клин to сужающийся канал.

2023-08-02 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: exit from the overbought zone.

2023-07-30 Signal in Stochastic changed from bullish reversal to bearish recovery. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: main and signal line crossing.

2023-07-30 Signal in RSI changed from bearish recovery to bearish weakening. RSI indicator is in the oversold territory and it heading north. These factors indicate that perhaps the downside trend is coming to an end. Last signal: exit from the overbought zone.


Current temperature: 1.79
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 1
Target Price Mean 12.00
Mean unverified/preliminary 12.00 / 12.00
Target Price Low / High 12.00 / 12.00
Median / STD DEV 12.00 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total None Buy Sell
rsi Sell Sell Sell
macd ActivelyBuy None None
stoch ActivelyBuy None None
ma20 None ActivelyBuy None
ma50 ActivelyBuy None None
ma100 Sell Buy None
Candlestick PatternOct. 3, 2024 Three Gaps Down - pattern is a made up of four black candlesticks. Pattern appears on a uptrend and consists of three consecutive days each gapping lower on the open. Considered to be a bullish reversal pattern.
ISIN IL0011313900
ceo Mr. Allen Baharaff
Website https://www.galmedpharma.com
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.